Urokinase‐type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer (Q73302682)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Urokinase‐type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer (English)

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

26 December 2023

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

26 December 2023

author name string

Takeshi Kaneko

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hiroyuki Konno

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Megumi Baba

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Tatsuo Tanaka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Satoshi Nakamura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12708473

26 December 2023

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

2 November 2019

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1349-7006.2003.tb01350.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12708473

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1349-7006.2003.tb01350.x

26 December 2023

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1349-7006.2003.tb01350.x

26 December 2023

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

26 December 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

43-49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

The urokinase-type plasminogen activator system in cancer metastasis: a review

2 November 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Plasminogen activator system in human breast cancer

26 December 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

The role of proteolytic enzymes in cancer invasion and metastasis

26 December 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma

26 December 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues

26 December 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients

26 December 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

26 December 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

26 December 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

26 December 2023

Tumor angiogenesis

15

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers

26 December 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Vascular permeability factor, an endothelial cell mitogen related to PDGF

26 December 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract

26 December 2023

18

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Prognostic value of vascular endothelial growth factor expression in gastric carcinoma

26 December 2023

19

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Vascular endothelial growth factor: molecular and biological aspects

26 December 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis

26 December 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

26 December 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Matrix metalloproteinases

26 December 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size

26 December 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer.

26 December 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Differing expression of MMPs-1 and -9 and urokinase receptor between diffuse- and intestinal-type gastric carcinoma

26 December 2023

26

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Prognostic factors in gastric cancer

26 December 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Prognostic impact of stromal cell-derived urokinase-type plasminogen activator in gastric carcinoma

26 December 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines

26 December 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Prognostic value of the plasminogen activation system in patients with gastric carcinoma

26 December 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

26 December 2023

32

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

26 December 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

26 December 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice

26 December 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

26 December 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

26 December 2023

38

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling

26 December 2023

39

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells

26 December 2023

41

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells

26 December 2023

42

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Tumor-associated proteases and inhibitors in gastric cancer: analysis of prognostic impact and individual risk protease patterns

26 December 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer

26 December 2023

45

1 reference

https://api.crossref.org/works/10.1111/J.1349-7006.2003.TB01350.X

26 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12708473%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference